z-logo
Premium
P3‐416: Differential TGF‐β‐Smad 2/3 and BMP‐Smad 1/5/8 pathway activation promotes macrophage Aβ phagocytosis
Author(s) -
Gate David,
Rezai-Zadeh Kavon,
Goodridge Helen,
Rodriguez Javier,
Jodry Dominique,
Underhill David,
Town Terrence
Publication year - 2010
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2010.05.1959
Subject(s) - smad , microbiology and biotechnology , signal transduction , phosphorylation , biology , cancer research , immunology
impairment of cognitive function. Conclusions: Our studies provide strong evidence that the N-termini of amyloid peptides influence their characteristics. This is primarily caused by a loss of N-terminal charge and solubility which increases aggregation propensity and, interestingly, influence on LTP. Likewise, novel transgenic animal models overproducing N-truncated Abeta develop an early phenotype. Thus, an accumulation of N-truncated amyloid as described for human AD might contribute to the pathogenesis due to the changes in the molecular properties. The data suggest that suppression of QC-catalyzed pGlu-formation provides potential for development of a treatment paradigm to prevent Aband inflammation-driven pathophysiology in AD, FDD and FBD.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom